No FDA status Not FDA-approved Compound AOD-9604 Mechanism Modified GH fragment
Bulk pricing applies to vials and bacteriostatic water (not pens)
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Using them can lead to failed tests and suspensions
This article covers the actual temperature thresholds that cause measurable degradation, how to assess whether an exposed vial is still viable, and what preparation mistakes compound the damage when BPC-157 left out fridge protocols are violated